|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ≥2025 |
| Treated |
|
|
|
|
|
|
|
| Base 2017 Elimination | 600 600 | 1200 1200 | 1100 1500 | 1100 2000 | 300 10,000 | 300 22,000 | 300 35,000 |
| Newly Diagnosed |
|
|
|
|
|
|
|
| Base 2017 Elimination | 1900 1900 | 1900 1900 | 1900 5000 | 1900 8000 | 1900 15,000 | 1900 25,000 | 1900 34,000 |
| Fibrotic Stage |
|
|
|
|
|
|
|
| Base 2017 Elimination | ≥F3 ≥F3 | ≥F0 ≥F0 | ≥F0 ≥F0 | ≥F0 ≥F0 | ≥F0 ≥F0 | ≥F0 ≥F0 | ≥F0 ≥F0 |
| Treated Age |
|
|
|
|
|
|
|
| Base 2017 Elimination | 15 - 79 15 - 79 | 15 - 79 15 - 79 | 15 - 79 15 - 79 | 15 - 79 15 - 79 | 15 - 79 15 - 79 | 15 - 79 15 - 79 | 15 - 79 15 - 79 |
| SVR |
|
|
|
|
|
|
|
| Base 2017 Elimination | 95% 95% | 95% 95% | 95% 95% | 95% 95% | 95% 95% | 95% 95% | 95% 95% |